-
EP3205334
European procedure
Extract from the Register of European Patents
EP About this file: EP3205334
| EP3205334 - METHOD AND COMPOSITION FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA [Right-click to bookmark this link] | Status | Patent revoked Status updated on 26.03.2025 Database last updated on 30.04.2025 | |
| Former | The patent has been granted Status updated on 27.03.2020 | ||
| Former | Grant of patent is intended Status updated on 05.03.2020 | ||
| Former | Request for examination was made Status updated on 23.02.2018 | ||
| Former | The application has been published Status updated on 14.07.2017 | Most recent event Tooltip | 28.03.2025 | Revocation of patent | published on 30.04.2025 [2025/18] | Applicant(s) | For all designated states Santen Pharmaceutical Co., Ltd. 9-19, Shimoshinjo 3-chome Higashiyodogawa-ku Osaka-shi Osaka 533-8651 / JP | For all designated states AGC Inc. 5-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-8405 / JP | [2018/39] |
| Former [2017/33] | For all designated states Santen Pharmaceutical Co., Ltd. 9-19, Shimoshinjo 3-chome Higashiyodogawa-ku Osaka-shi Osaka 533-8651 / JP | ||
| For all designated states ASAHI GLASS COMPANY, LIMITED 5-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-8405 / JP | Inventor(s) | 01 /
REUNAMAKI, Timo Jakalakatu 4 33820 Tampere / FI | 02 /
PELLINEN, Pertti Simunantie 12C7 33880 Lempaala / FI | 03 /
OKSALA, Olli Hirvikatu 24 E 20 33240 Tampere / FI | 04 /
LEHMUSSAARI, Kari Silakatu 3 33580 Tampere / FI | [2017/33] | Representative(s) | Müller-Boré & Partner Patentanwälte PartG mbB Friedenheimer Brücke 21 80639 München / DE | [2017/33] | Application number, filing date | 17000440.2 | 28.05.2009 | [2017/33] | Priority number, date | EP20080397513 | 30.05.2008 Original published format: EP 08397513 | [2017/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3205334 | Date: | 16.08.2017 | Language: | EN | [2017/33] | Type: | B1 Patent specification | No.: | EP3205334 | Date: | 29.04.2020 | Language: | EN | [2020/18] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 29.05.2017 | Classification | IPC: | A61K9/08, A61K47/10, A61K47/26, A61K47/18, A61K31/5575 | [2017/33] | CPC: |
A61K9/0048 (EP,KR,US);
A61K31/5575 (EP,KR,US);
A61K47/10 (EP,KR,US);
A61K47/183 (EP,KR,US);
A61K47/26 (EP,KR,US);
A61K9/08 (EP,KR,US);
A61P27/02 (EP);
A61P27/06 (EP,US);
A61P43/00 (EP);
A61P9/12 (EP);
A61K2800/80 (KR);
A61K47/02 (US);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2018/13] |
| Former [2017/33] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | VERFAHREN UND ZUSAMMENSETZUNG ZUR BEHANDLUNG VON AUGENHOCHDRUCK UND GLAUKOM | [2017/33] | English: | METHOD AND COMPOSITION FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA | [2017/33] | French: | PROCÉDÉ ET COMPOSITION POUR LE TRAITEMENT DE L'HYPERTENSION OCULAIRE ET DU GLAUCOME | [2017/33] | Examination procedure | 17.03.2017 | Date on which the examining division has become responsible | 15.02.2018 | Amendment by applicant (claims and/or description) | 15.02.2018 | Examination requested [2018/13] | 06.03.2020 | Communication of intention to grant the patent | 17.03.2020 | Receipt of the translation of the claim(s) | 19.03.2020 | Fee for grant paid | 19.03.2020 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP09754864.8 / EP2306977 | EP14001862.3 / EP2772249 | Divisional application(s) | EP20164602.3 / EP3714877 | EP21217057.5 / EP4035656 | EP23202597.3 / EP4289446 | EP25150453.6 / EP4512424 | Opposition(s) | Opponent(s) | 01
26.01.2021
28.01.2021
ADMISSIBLE Cooke, Richard Elkington and Fife LLP Patents Department 3-4 Holborn Circus London EC1N 2HA / GB Opponent's representative Elkington and Fife LLP, et al, et al Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | [2021/09] | 16.02.2021 | Invitation to proprietor to file observations on the notice of opposition | 23.06.2021 | Reply of patent proprietor to notice(s) of opposition | 29.04.2022 | Date of oral proceedings | 02.08.2022 | Despatch of interlocutory decision in opposition | 02.08.2022 | Despatch of minutes of oral proceedings | 25.02.2025 | Legal effect of revocation of patent [2025/18] | 18.03.2025 | Despatch of communication that the patent will be revoked | Appeal following opposition | 12.10.2022 | Appeal received No. T2275/22 | 12.10.2022 | Payment of appeal fee | 12.12.2022 | Statement of grounds filed | 25.02.2025 | Result of appeal procedure: revocation of the patent | 18.03.2025 | Despatch of the decision of the Board of Appeal | 11.10.2022 | Appeal received No. T2275/22 | 11.10.2022 | Payment of appeal fee | 01.11.2022 | Statement of grounds filed | 25.02.2025 | Result of appeal procedure: revocation of the patent | 18.03.2025 | Despatch of the decision of the Board of Appeal | 25.02.2025 | Date of oral proceedings | Fees paid | Renewal fee | 30.03.2017 | Renewal fee patent year 03 | 30.03.2017 | Renewal fee patent year 04 | 30.03.2017 | Renewal fee patent year 05 | 30.03.2017 | Renewal fee patent year 06 | 30.03.2017 | Renewal fee patent year 07 | 30.03.2017 | Renewal fee patent year 08 | 30.03.2017 | Renewal fee patent year 09 | 14.05.2018 | Renewal fee patent year 10 | 23.05.2019 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 29.04.2020 | MC | 29.04.2020 | MK | 29.04.2020 | MT | 29.04.2020 | LU | 28.05.2020 | [2022/32] |
| Former [2022/28] | CY | 29.04.2020 | |
| MC | 29.04.2020 | ||
| MT | 29.04.2020 | ||
| LU | 28.05.2020 | ||
| Former [2021/15] | MC | 29.04.2020 | |
| LU | 28.05.2020 | ||
| Former [2021/12] | MC | 29.04.2020 | Documents cited: | Search | [Y]WO0003736 (ALCON LAB INC [US]); | [Y]EP1321144 (SANTEN PHARMACEUTICAL CO LTD [JP], et al); | [Y]EP1825855 (SANTEN PHARMACEUTICAL CO LTD [JP]); | by applicant | US5409125 | US5614172 | EP0850926 | US5807892 | US5886035 | EP0969846 | EP1011728 | US6096783 | US6241124 | EP1115406 | US6344477 | EP1321144 | EP1349580 | EP1547599 | EP1666043 | WO2007042262 | EP1825855 | EP1829545 | US2007248697 | EP1905453 | EP1916002 | Opposition | WO0003736 | EP1321144 | US2005287325 | EP1825855 |